Stocks
SpaceX stock can keep climbing, but investors should watch whether Starlink profits and AI execution can support its rich valuation.
The health damage of loneliness is similar to heavy smoking and obesity
Stocks
Tilray Brands tried one thing, and it didn't work; now it is trying another approach.
Stocks
Stocks
Stocks
You don't want to wait until you're about to retire to start asking this question.
This adventure travel operator, known for eco-focused expeditions, reported a notable insider sale amid strong year-over-year gains.
The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about 3% year-to-date while the broader market grinds higher. The good news for XLV holders: the fund has clawed back roughly 14% over the past year, and the 2026 setup looks meaningfully
The energy sector is hot this year, but EQT shares are in a rut. There are still some compelling traits to this natural gas company.
TJX's sales grow faster during times of economic uncertainty.
Most investors focus on how many AI chips companies like Nvidia sell to gauge AI demand. But Micron investors may want to watch a different number.
“I’m afraid I’m in a bad place.”
With its stock price soaring this year, has the fuel cell maker's valuation outrun its business?
There's a compelling case to be made for both sides.
There's a big reason this approach could come back to bite you.